{"disease":{"id":"leptomeningeal-metastases","name":"leptomeningeal metastases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04343573","title":"Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06971406","title":"High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Qiming Wang","has_results":false},{"nct_id":"NCT06728865","title":"Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Li-kun Chen","has_results":false},{"nct_id":"NCT04233021","title":"Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Intergroupe Francophone de Cancerologie Thoracique","has_results":false},{"nct_id":"NCT03275402","title":"131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"Y-mAbs Therapeutics","has_results":true},{"nct_id":"NCT06766591","title":"Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Jiangsu Province Nanjing Brain Hospital","has_results":false},{"nct_id":"NCT05289908","title":"Intrathecal Pemetrexed for Leptomeningeal Metastasis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT06462092","title":"Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":34,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT03520504","title":"Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06132698","title":"Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":17,"lead_sponsor_name":"West China Hospital","has_results":false},{"nct_id":"NCT03719768","title":"Avelumab With Radiotherapy in Patients With Leptomeningeal Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":false},{"nct_id":"NCT03101579","title":"Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false},{"nct_id":"NCT03661424","title":"BATs in Patients With Breast Cancer and Leptomeningeal Metastases","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT03711422","title":"Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"National Cancer Centre, Singapore","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}